-
Biotech and Money London Adds Pharma Forum Day to Help UK Life Science Companies Assess Partnership Potential with Big Pharma
Biotech and Money London has added a Pharma Forum Day to help UK life science Executives assess collaboration opportunities with many of the industry’s Big Pharma players.
-
Synpromics Announces Collaboration with Avalanche Biotechnologies
Synpromics Ltd, a leading synthetic biology company, is pleased to announce a collaboration with Avalanche Biotechnologies Inc.
-
Controlling the ‘Social Life’ of Proteins Aims to Transform Drug Discovery
A new £3.4 million programme will develop new tools to understand which interactions between proteins in the human body are relevant to disease.
-
Sciad, Medherant & Ibuprofen Patches
The Sciad team was pleased to see all the recent coverage of Medherant and their work with the University of Warwick to develop an Ibuprofen patch based on Medherant’s novel patch technology. Sciad has been working with Medherant to develop their branding and a name for their patch technology, to help Medherant better market their…
-
AGTC and Synpromics Limited Announce R&D Collaboration to Develop Synthetic Promoters for Enhanced Gene Therapy Candidates
GAINESVILLE, Fla., CAMBRIDGE, Mass. and EDINBURGH, Scotland, 9th December 2015 / Sciad Newswire / Applied Genetic Technologies Corporation (Nasdaq: AGTC), a biotechnology company conducting human clinical trials of adeno-associated virus (AAV)-based gene therapies for the treatment of rare eye diseases, and Synpromics Limited, a leading synthetic promoter development company backed by Calculus Capital, today announced they have entered…
-
Cypralis Limited announces collaboration with Johnson & Johnson Innovation in the field of neurodegenerative diseases
Ongar, UK, 7th December 2015 / Sciad Newswire / Cypralis, a life sciences company focussed on the discovery of therapeutics for the modulation of peptidyl-prolyl isomerases (PPIases), has entered into a collaboration with Janssen Pharmaceuticals Inc., one of the Janssen Pharmaceutical Companies of Johnson & Johnson. The collaboration, facilitated by Johnson & Johnson Innovation, aims to develop…
-
University of Edinburgh and Selcia Achieve Key Milestones in Bid to Develop New Drugs to Target Sleeping Sickness
Ongar, UK, 30th November 2015 / Sciad Newswire / Scientists from the University of Edinburgh, working with Selcia, an international life sciences contract research organisation, have successfully passed the 20-month milestone targets of a 30-month Wellcome Trust SDDi £2.5 million project to design novel treatments for sleeping sickness. The aim of the project is to design a drug…
-
MedTech Engine – Jump-Starting Europe’s Medical Device Sector
London, United Kingdom, 24th November 2015 / Sciad Newswire / A new digital platform to foster market success for innovation in Europe’s medical device sector launches today. Providing a hub of vital resources, MedTech Engine will offer key connections and information for people in medtech worldwide. The brainchild of a team of entrepreneurs located in Strasbourg and London,…
-
Coming Soon to Big Pharma: Disruptive Innovation
A changing pharmaceutical industry needs diversity, new thinking and multi-sector experience, all of which were delivered in spades at Pharma Integrates 2015.
-
Desktop Genetics Partners with Transcriptic Inc
San Francisco, USA, 5th November 2015 / Sciad Newswire / Desktop Genetics Ltd (“DTG”), a software company revolutionizing the way biologists use CRISPR/Cas9 gene editing technology, announced today that it has signed a partnership agreement with Transcriptic Inc. (Transcriptic), a California based robotic cloud laboratory for Life Sciences and Synthetic Biology. The partnership, announced at the SynBioBeta conference in California, will combine…